Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Merrill

Showing results (31-40 of 414) with videos related to

Pageof 42
Sort By:
Current Rheumatology Reports|September 12, 2003
Rituximab in antiphospholipid syndromeJoan T Merrill
Current Rheumatology Reports|September 12, 2003
Cyclosporin A in antiphospholipid syndromeJoan T Merrill
Current Rheumatology Reports|September 12, 2003
The antiphospholipid syndrome and atherosclerosis: clue to pathogenesisJoan T Merrill
Current Rheumatology Reports|July 30, 2008
Is individualized medicine on the horizon for lupus?Joan T Merrill
Current Rheumatology Reports|July 30, 2008
Biomarkers relevant to atacicept effects in systemic lupus erythematosus patientsJoan T Merrill
Current Opinion in Rheumatology|August 23, 2002
Regulation of the vasculature: clues from lupusJoan T Merrill
The Lancet. Rheumatology|January 27, 2024
Systemic lupus erythematosus: diverting progress to chase rare side effects?Joan T Merrill
Arthritis & Rheumatology (Hoboken, N.J.)|February 21, 2022
ReplyJoan T Merrill
Current Rheumatology Reports|September 10, 2002
Recurrent pregnancy loss with the antiphospholipid antibody: a systematic review of therapeutic trialsJoan T Merrill
Arthritis & Rheumatology (Hoboken, N.J.)|May 27, 2021
What Did Not Work: The Drug or the Trial?Joan T Merrill
Pageof 42

Showing results (31-40 of 414) with videos related to

Sort By:
Pageof 42
Current Rheumatology Reports|September 12, 2003
Rituximab in antiphospholipid syndromeJoan T Merrill
Current Rheumatology Reports|September 12, 2003
Cyclosporin A in antiphospholipid syndromeJoan T Merrill
Current Rheumatology Reports|September 12, 2003
The antiphospholipid syndrome and atherosclerosis: clue to pathogenesisJoan T Merrill
Current Rheumatology Reports|July 30, 2008
Is individualized medicine on the horizon for lupus?Joan T Merrill
Current Rheumatology Reports|July 30, 2008
Biomarkers relevant to atacicept effects in systemic lupus erythematosus patientsJoan T Merrill
Current Opinion in Rheumatology|August 23, 2002
Regulation of the vasculature: clues from lupusJoan T Merrill
The Lancet. Rheumatology|January 27, 2024
Systemic lupus erythematosus: diverting progress to chase rare side effects?Joan T Merrill
Arthritis & Rheumatology (Hoboken, N.J.)|February 21, 2022
ReplyJoan T Merrill
Current Rheumatology Reports|September 10, 2002
Recurrent pregnancy loss with the antiphospholipid antibody: a systematic review of therapeutic trialsJoan T Merrill
Arthritis & Rheumatology (Hoboken, N.J.)|May 27, 2021
What Did Not Work: The Drug or the Trial?Joan T Merrill
Pageof 42